Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
156.9 USD | +0.77% | -1.04% | +26.45% |
Sales 2024 * | 260M 20.82B | Sales 2025 * | 423M 33.89B | Capitalization | 4.47B 358B |
---|---|---|---|---|---|
Net income 2024 * | 46M 3.68B | Net income 2025 * | 146M 11.69B | EV / Sales 2024 * | 15 x |
Net cash position 2024 * | 564M 45.12B | Net cash position 2025 * | 739M 59.15B | EV / Sales 2025 * | 8.82 x |
P/E ratio 2024 * |
82.6
x | P/E ratio 2025 * |
30.7
x | Employees | 229 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.22% |
Latest transcript on Krystal Biotech, Inc.
1 day | +0.77% | ||
1 week | -1.04% | ||
Current month | -11.83% | ||
1 month | -9.93% | ||
3 months | +35.21% | ||
6 months | +32.94% | ||
Current year | +26.45% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 14/04/16 | |
Suma M. Krishnan
FOU | Founder | 59 | 14/04/16 |
Ram Kamineni
CTO | Chief Tech/Sci/R&D Officer | - | 30/06/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Janney
BRD | Director/Board Member | 58 | 31/10/16 |
Suma M. Krishnan
FOU | Founder | 59 | 14/04/16 |
Dino Rossi
BRD | Director/Board Member | 69 | 31/05/17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.16% | 0 M€ | 0.00% | - | |
0.14% | 0 M€ | 0.00% | - | |
0.06% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 156.9 | +0.77% | 165,898 |
25/04/24 | 155.7 | -2.12% | 242,424 |
24/04/24 | 159 | -1.85% | 237,974 |
23/04/24 | 162 | +3.05% | 223,172 |
22/04/24 | 157.2 | -0.81% | 341,813 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.45% | 4.47B | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- KRYS Stock